2017
DOI: 10.1007/s00392-017-1192-0
|View full text |Cite
|
Sign up to set email alerts
|

Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry

Abstract: management of patients with CS changed with a steep decrease of IABP implantations. Mortality of patients with CS decreased over the last 10 years. Especially, performance of successful PCI was associated with a reduction of mortality, indicating the crucial role of early revascularization to improve prognosis in this high-risk cohort of STEMI-patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
53
1
7

Year Published

2019
2019
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(73 citation statements)
references
References 37 publications
12
53
1
7
Order By: Relevance
“…Multivessel CAD was associated with worse survival in ACS‐related CS, as previously shown . No difference in mortality between different IRAs was discovered, similar to one previous study, even though mortality rates were numerically higher in LM and LAD in comparison to RCA and LCX.…”
Section: Resultssupporting
confidence: 89%
“…Multivessel CAD was associated with worse survival in ACS‐related CS, as previously shown . No difference in mortality between different IRAs was discovered, similar to one previous study, even though mortality rates were numerically higher in LM and LAD in comparison to RCA and LCX.…”
Section: Resultssupporting
confidence: 89%
“…Female patients are typically older, and elderly patients exhibit more comorbidities [24,25]. Myocardial infarction is complicated by cardiogenic shock more often in these patients [26]. These comorbidities and hemodynamic instability usually go along with prolonged pre-hospital transportation delay [11].…”
Section: Discussionmentioning
confidence: 99%
“…Dies dürfte in erster Linie einer besseren präklinischen Versorgung geschuldet sein, durch die Patienten im CS nunmehr häufiger noch in ein Krankenhaus transportiert werden können und nicht im häuslichen Umfeld versterben [1 -6]. Trotz aller beim AMI erreichten Verbesserungen mit einer deutlichen Mortalitätsreduktion in den letzten Jahrzehnten [7] ist die Mortalität im Falle eines CS weiterhin sehr hoch und liegt bei einer Rate von 40-50 % nach einem Monat [3,5,8,9]. Die aktuellen Empfehlungen und Therapieansätze für Deutschland und Österreich basieren auf der im Jahr 2010 initial erschienenen S3-Leitlinie, welche gerade in einer aktualisierten Revision veröffentlicht wurde [10,11].…”
Section: Introductionunclassified